Particularly important is hepatic cholesterol homeostasis, which is regulated by several nuclear transcription factors; among these, three have been associated with MASLD pathogenesis: SREBP-2 (sterol regulatory element binding protein-2), FXR (farnesoid X receptor), and LXR (liver X receptor). The gene discussed is SREBF2; the disease is metabolic dysfunction-associated steatotic liver disease.